Facebook
Britain's News Portal
Around The Clock
BREAKING
Loading latest headlines…

NHS Trust Apologises for Unnecessary Chemotherapy Harm to Cancer Patients

An NHS trust has apologised after a report found cancer patients were severely harmed by years of unnecessary chemotherapy treatment, with some misdiagnosed or incorrectly told they would die if treatment stopped.

  • A Royal College of Physicians report found cancer patients at University Hospitals Coventry and Warwickshire NHS trust received years of unnecessary chemotherapy.
  • The report examined 20 brain tumour patient cases, finding 15 received unsatisfactory care and five required improvement.
  • The trust has apologised for failures in its neuro-oncology service under a retired clinical oncologist.

Cancer patients at an NHS trust were severely harmed after receiving years of unnecessary chemotherapy, a report has found. The Royal College of Physicians (RCP) report stated that some individuals were misdiagnosed and given inappropriate treatment courses, while others were incorrectly informed that stopping chemotherapy would be fatal.

The report focused on brain tumour patients at University Hospitals Coventry and Warwickshire NHS trust. Concerns were raised by colleagues of Prof Ian Brown, a clinical oncologist who retired in 2023, after his patients were found to be on long-term, repeated cycles of the chemotherapy drug temozolomide (TMZ) without evidence of benefit.

The RCP report examined 20 patient cases, concluding that 15 received unsatisfactory care and five cases required improvement. One patient reportedly received over 10 years of chemotherapy after being incorrectly diagnosed with deadly glioblastoma, which was later identified as a low-grade tumour not requiring chemotherapy.

Leaders at the trust, Prof Andy Hardy and Sue Noyes, have apologised for the failures within their neuro-oncology service under the care of Prof Ian Brown. They stated that meaningful action is being taken and that they will learn from the findings openly and transparently.

The legal firm Brabners, representing more than 40 patients, is calling for an independent public inquiry. The report recommends that the trust ensures all living patients treated with more than 12 cycles of TMZ have their cases independently reviewed.

Why this matters: The findings raise serious questions about individual clinical decisions and historical governance within the NHS trust's neuro-oncology service.

Related Articles

Get the news that matters.

Join thousands of readers getting the best of British news straight to their inbox.